Last C$0.10 CAD
Change Today 0.00 / 0.00%
Volume 0.0
HTL On Other Exchanges
As of 3:59 PM 09/5/14 All times are local (Market data is delayed by at least 15 minutes).

hamilton thorne ltd (HTL) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/28/14 - C$0.16
52 Week Low
03/3/14 - C$0.04
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HAMILTON THORNE LTD (HTL)

Related News

No related news articles were found.

hamilton thorne ltd (HTL) Related Businessweek News

No Related Businessweek News Found

hamilton thorne ltd (HTL) Details

Hamilton Thorne Ltd., through its wholly owned subsidiary, Hamilton Thorne, Inc., develops, manufactures, and sells precision laser systems and advanced image analysis systems for living cell applications in the fertility, stem cell, and developmental biology research markets. Its product portfolio consists of XYRCOS for clinical laser assisted hatching and biopsy applications in animal and stem cell; XYClone laser system for stem cell research, gene targeting, knock out mouse production, SCNT, ICSI, IVF, and assisted hatching; ZILOS-tk for laser assisted hatching, trophectoderm biopsy, and blastomere biopsy for clinical human applications; LYKOS laser with built-in RED-i target locator for clinical applications; and Stiletto for ablation of unwanted cells. The company also offers IMSI-Strict software solution that offers real-time, automated computer analysis of live sperm morphology under high magnification; and CIVA, a custom software product for the capture of microscope images and videos. In addition, it provides computer assisted sperm analyzers, as well as sperm analysis accessories, including Accu-beads for quality control of sperm counting, IDENT fluorescent stain for precise sperm counts, VIADENT fluorescent stains for viability studies, 2X-CEL disposable sperm analysis chambers, and the MiniTherm portable stage warmer. Further, the company offers micromanipulation products, such as XenoWorks Micromanipulator, XenoWorks Digital Microinjector, and XenoWorks Analog Microinjector, as well as micropipette puller, laser based micropipette puller, flaming/brown micropipette puller, and vertical micropipette puller. Hamilton Thorne Ltd. sells its products through its direct sales force and through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments worldwide. The company was founded in 2001 and is based in Beverly, Massachusetts.

Founded in 2001

hamilton thorne ltd (HTL) Top Compensated Officers

Chief Executive officer, President and Direct...
Total Annual Compensation: $189.6K
Co-Founder, Chief Technology Officer, Senior ...
Total Annual Compensation: $141.6K
Chief Financial Officer and Vice President of...
Total Annual Compensation: $154.0K
Vice President of Engineering
Total Annual Compensation: $140.0K
Compensation as of Fiscal Year 2013.

hamilton thorne ltd (HTL) Key Developments

Hamilton Thorne Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Hamilton Thorne Ltd. reported earnings results for the second quarter and six months ended June 30, 2014. For the quarter, sales were $2,214,501 against $1,827,284 a year ago. Operating income was $269,958 against $51,171 a year ago. Net income was $209,392 or $0.004 per basic and diluted share against net loss of $13,594 or $0.000 per basic and diluted share a year ago. EBITDA was $289,889 against $69,771 a year ago. For the six months, sales were $4,179,784 against $3,568,582 a year ago. Operating income was $374,280 against operating loss of $52,624 a year ago. Net income was $264,146 or $0.005 per basic and diluted share against net loss of $134,906 or $0.003 per basic and diluted share a year ago. EBITDA was $414,142 against $35,747 a year ago. Cash generated by operations improved to $140,000 for the quarter and $245,000 for the year, the fourth consecutive quarter of positive cash generation.

Hamilton Thorne Ltd. Receives Notification of Grant of Patent Right and CFDA Approval to Market its LYKOS (R) Laser System in China

Hamilton Thorne Ltd. announced that it has received notice that the China Food and Drug Administration (CFDA) has approved the company's cutting edge LYKOS(R) for sale to clinical markets in China. Concurrent to this, the company announced that it has received a Notification to Grant Patent Right for Invention covering the Modular Laser Assembly that is at the heart of its LYKOS system. The LYKOS laser system provides clinicians with exceptional ease of use for intricate assisted reproduction and pre-implantation genetic testing procedures, such as laser-assisted hatching, embryo biopsy and laser-pulse blastocyst collapse for vitrification. The LYKOS offers a significant advantage over competitive systems due to its integration of the laser diode within a custom microscope objective. This unique modular assembly has many benefits, including: Protection of the laser diode from environmental contaminants that can impair laser power, accuracy and functionality. The ability to 'lock' the laser alignment for embryo safety, even when the LYKOS is moved between microscopes and laboratories. Built-in RED-i(R) target locator to ensure accuracy of laser application. Compatibility with all major brands of microscopes, without the need of new hardware components.

Hamilton Thorne and Halotech DNA SL Sign Agreement to Collaborate on Development and Marketing Programs to Accelerate the Sales of their Products

Hamilton Thorne and Halotech DNA SL announced that they have signed an agreement to collaborate on development and marketing programs to accelerate the sales of their products.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HTL:CN C$0.10 CAD 0.00

HTL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Brooks Automation Inc $10.83 USD +0.12
Tsubakimoto Chain Co ¥884.00 JPY -10.00
View Industry Companies

Industry Analysis


Industry Average

Valuation HTL Industry Range
Price/Earnings 9.1x
Price/Sales 0.6x
Price/Book NM Not Meaningful
Price/Cash Flow 9.1x
TEV/Sales 0.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HAMILTON THORNE LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at